Molecular Modeling and Structure–Activity Relationships for a Series of Benzimidazole Derivatives as Cruzain Inhibitors

Abstract

These results demonstrate the relevance of the QSAR models to guide the design of structurally related benzimidazole derivatives with improved potency.